Table 2.
Odds ratios (OR) and 95% confidence intervals (CI) for height loss in relation to albumin level
| Albumin tertile levels | p | 1-SD increment of albumin | |||
|---|---|---|---|---|---|
| T1 (Low) | T2 (Middle) | T3 (High) | |||
| Men | |||||
| No. of participants | 1869 | 1712 | 1423 | ||
| No. of participants with height loss (percentage) | 525 (28.1) | 415 (24.2) | 310 (21.8) | ||
| Age-adjusted ORs | Reference | 0.91 (0.78, 1.06) | 0.84 (0.72, 0.998) | 0.043 | 0.92 (0.86, 0.98) |
| Multivariable ORs | Reference | 0.91 (0.78, 1.06) | 0.85 (0.72, 1.01) | 0.052 | 0.92 (0.86, 0.98) |
| Women | |||||
| No. of participants | 716 | 957 | 960 | ||
| No. of participants with height loss (percentage) | 209 (29.2) | 233 (24.3) | 216 (22.5) | ||
| Age-adjusted ORs | Reference | 0.80 (0.64, 1.00) | 0.71 (0.57, 0.89) | 0.003 | 0.86 (0.79, 0.94) |
| Multivariable ORs | Reference | 0.81 (0.65, 1.02) | 0.71 (0.57, 0.89) | 0.003 | 0.86 (0.79, 0.95) |
Multivariable ORs: further adjusted for age, drinking status, smoking status, high BMI, hypertension, diabetes, dyslipidemia, and chronic kidney disease. Height loss: the highest quartile of height loss per year. Albumin tertile levels for men were < 4.5 g/dL for T1 (low), 4.5–4.6 g/dL or T2 (middle), and ≥ 4.7 g/dL for T3 (High), and for women the corresponding values were < 4.4 g/dL, 4.4–4.5 g/dL, and ≥ 4.6 g/dL. The 1-standard deviation increment of albumin was 0.2 g/dL in both men and women